SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-19-001672
Filing Date
2019-03-12
Accepted
2019-03-12 21:01:41
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 s3_031219.htm S-3 201292
2 EXHIBIT 5.1 exh_51.htm EX-5.1 34650
3 EXHIBIT 23.1 exh_231.htm EX-23.1 4173
4 GRAPHIC logo.jpg GRAPHIC 6135
5 GRAPHIC mccarthy.jpg GRAPHIC 3188
6 GRAPHIC mccarthy2.jpg GRAPHIC 5366
7 GRAPHIC mccarthy3.jpg GRAPHIC 1838
8 GRAPHIC kpmg.jpg GRAPHIC 1956
9 GRAPHIC kpmg2.jpg GRAPHIC 2296
10 GRAPHIC kpmg3.jpg GRAPHIC 4490
  Complete submission text file 0001171843-19-001672.txt   277185
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230218 | Film No.: 19676698
SIC: 2836 Biological Products, (No Diagnostic Substances)